Anthony S. Fiorino
CIK 1608901 · Chief Medical Officer and COO · last filed 2020-02-04
Anthony S. Fiorino is a Chief Medical Officer and COO who has filed 9 SEC Form 4 insider transactions across 3 companies since 2014. Across all open-market trades the lifetime net is +$20.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.6K
3
9
$20.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMMUNE PHARMACEUTICALS INC (IMNP) Delisted | Chief Medical Officer and COO | 75,000 | — | — | $18.9K | 3 | 2018-05-23 |
| NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Director | 78,000 | $0.00 | $8 | $0 | 2 | 2017-06-30 |
| BCLI | Chief Executive Officer | 2,200 | $0.75 | $1.6K | $1.8K | 1 | 2014-10-15 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-02-04 | — | Sell (S) | −75,000 | -$262 | |
| 2018-05-23 | IMMUNE PHARMACEUTICALS INC (IMNP) Delisted | Buy (P) | +25,000 | $6.0K | EDGAR |
| 2018-05-18 | IMMUNE PHARMACEUTICALS INC (IMNP) Delisted | Buy (P) | +50,000 | $12.9K | EDGAR |
| 2017-09-18 | IMMUNE PHARMACEUTICALS INC (IMNP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-30 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +50,000 | $50 | EDGAR |
| 2016-04-29 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +28,000 | $0 | EDGAR |
| 2014-10-15 | BCLI | Buy (P) | +500 | $1.8K | EDGAR |
| 2014-09-19 | — | Buy (P) | +800 | $3.1K | |
| 2014-09-16 | — | Buy (P) | +18,000 | $5.1K |